Barely Significant
← all excerpts

Randomised trial: survival benefit and safety of adjuvant dose-dense chemotherapy for node-positive breast cancer.

Br J Cancer · 2006 · PMC2361407 · PMID 16622463

1
hedged sentence
closest p
boldest claim

The sentences

showed a trendno p-value reported
Dose dense showed a trend for improved disease-free survival (DFS) and overall survival (OS).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.